Sanjiv Patel - Jan 16, 2024 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
President and CEO, Director
Signature
/s/ Brian Adams, as attorney-in-fact
Stock symbol
RLAY
Transactions as of
Jan 16, 2024
Transactions value $
$0
Form type
4
Date filed
1/18/2024, 04:19 PM
Previous filing
Sep 29, 2023
Next filing
Jul 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Award $0 +762K +45870.04% $0.00 764K Jan 16, 2024 Direct F1, F2
holding RLAY Common Stock 675K Jan 16, 2024 By The Patel Family Irrevocable Trust of 2019 F3
holding RLAY Common Stock 687K Jan 16, 2024 By The SSP Irrevocable Trust of 2020 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F2 Includes 762,360 shares underlying RSUs.
F3 These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.